To the Editor:

Invasive candidiasis remains a critical problem in intensive care units (ICUs) throughout the developed world.[1](#jgf2250-bib-0001){ref-type="ref"} Nonetheless, differentiating between those with and without invasive candidiasis among critically ill ICU patients, especially during the early phase of the clinical course, remains challenging. In these situations, it is helpful to be familiar with both the epidemiology of the disease and the typical clinical characteristics of patients with candidemia complicated by sepsis, one of the most common risk factors for candidemia.[2](#jgf2250-bib-0002){ref-type="ref"} Our aim was to describe the characteristics and clinical features of patients with candidemia admitted to the ICU due to sepsis.

This is a case series analysis from a sepsis substudy of the Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORECAST) study, a multicenter, prospective cohort study of patients with sepsis. FORECAST was conducted in 59 ICUs from January 2016 to March 2017 in Japan.[3](#jgf2250-bib-0003){ref-type="ref"} Adult patients (≥16 years) with severe sepsis or septic shock based on Sepsis‐2 criteria and admitted to a participating ICU were included. Among this population, we selected patients with candidemia diagnosed from blood culture results.

Of 1184 patients with sepsis, fifteen patients with candidemia were identified (Table [1](#jgf2250-tbl-0001){ref-type="table"}). Baseline characteristics are shown in Table [S1](#jgf2250-sup-0002){ref-type="supplementary-material"}. Six patients died prior to discharge from hospital. Among nine survivors, only one patient was able to return home after discharge (Table [S2](#jgf2250-sup-0002){ref-type="supplementary-material"}). The most common species among monomicrobial isolates was *C. albicans* (six patients). Three of the six patients with *C. albicans* and three of the nine patients with non--*C. albicans* died prior to discharge. Catheter‐related blood stream infection (CRBSI) was the most commonly identified source of infection (five patients), followed by lung and abdomen (four patients each). Among five patients with CRBSI, four patients were under 60 years old. All patients with CRBSI survived to discharge, while all patients with fungal pneumonia or empyema died.

###### 

Characteristics and outcome of fifteen patients with candidemia complicated by sepsis (n = 15)

  Age   Gender   Infection site   Admission source   Shock   Medication        Comorbidities                                         Antibiotic use before diagnosis   MV    Vasopressor use   SOFA score   APACHE II score   Blood culture      Antifungal drug      Antibiotics   LOS (d)                ICU‐FD (d)   Disposition   
  ----- -------- ---------------- ------------------ ------- ----------------- ----------------------------------------------------- --------------------------------- ----- ----------------- ------------ ----------------- ------------------ -------------------- ------------- ---------------------- ------------ ------------- ----------
  67    M        Abdomen          ED                 Yes     No                COPD                                                  Yes                               Yes   Yes               11           23                *C albicans*       *E faecium E coli*                 MEPM, VCM              17           0             Dead
  46    M        CRBSI            Ward (transfer)    No      No                                                                      Yes                               No    No                8            23                *C albicans*                            F‐FLCZ                               74           8             Transfer
  76    M        Lung             Ward (transfer)    Yes     Anticancer drug   Metastatic malignant tumor                            Yes                               Yes   No                12           37                *C tropicalis*                          MCFG          MEPM, VCM              27           0             Dead
  45    M        Lung             Ward (transfer)    Yes     Steroid           Connective tissue disease, Peptic ulcer disease, DM   Yes                               No    Yes               12           28                *C albicans*       *C striatum*         F‐FLCZ        MEPM, VCM              15           0             Dead
  46    M        CRBSI            Ward (transfer)    Yes     No                                                                      No                                NA    Yes               NA           NA                *C glabrata*                            FLCZ                                 11           23            Transfer
  78    M        Abdomen          Ward (transfer)    No      Steroid           Connective tissue disease                             No                                No    No                3            20                *C glabrata*       *E coli*             MCFG          MEPM                   27           8             Transfer
  60    M        CRBSI            Ward (transfer)    Yes     No                Cerebrovascular disease, DM, hemiplegia               No                                Yes   Yes               17           31                *C tropicalis*     *P mirabilis*                      MEPM, VCM              27           15            Transfer
  85    W        Abdomen          ED                 Yes     Anticoagulant     Dementia                                              No                                No    Yes               8            15                *C parapsilosis*   *Pseudomonas sp*.                  CMZ                    96           9             Transfer
  30    W        CRBSI            Ward (transfer)    No      No                                                                      Yes                               Yes   Yes               9            30                *C parapsilosis*                        F‐FLCZ        CFPM                   142          22            Home
  62    W        Wound            Ward (transfer)    Yes     No                                                                      No                                Yes   Yes               11           13                *C glabrata*       *P mirabilis*        VRCZ, MCFG    CTRX, MEPM, VCM, DAP   19           0             Dead
  86    M        CRBSI            Ward (transfer)    Yes     No                Cerebrovascular disease, COPD                         Yes                               No    Yes               NA           23                *C tropicalis*                                        MEPM                   47           23            Transfer
  46    W        Abdomen          Ward (transfer)    Yes     No                                                                      Yes                               Yes   Yes               7            18                *C albicans*                                          MEPM                   165          0             Transfer
  75    M        Lung             Ward (transfer)    Yes     No                Malignancy (solid)                                    Yes                               Yes   Yes               8            17                *C glabrata*                            L‐AMB         CZOP                   149          0             Dead
  71    W        Lung             Ward (transfer)    No      No                Cerebrovascular disease, DM, liver disease            Yes                               No    Yes               11           32                *C albicans*                                          PIPC/TAZ               6            0             Dead
  71    M        Other site       Ward (transfer)    No      No                DM, malignancy (solid)                                Yes                               Yes   Yes               11           32                *C albicans*                                          PIPC/TAZ, CLDM         90           11            Transfer

APACHE II, acute physiology and chronic health evaluation II; CFPM: cefepime; CLDM: clindamycin; CMZ: cefmetazole; COPD: chronic obstructive pulmonary disease; CRBSI: catheter‐related blood stream infection; CTRX: ceftriaxone; CZOP: cefozopran; DAP: daptomycin; DM: diabetes mellitus; ED: emergency department; F‐FLCZ: fosfluconazole; FLCZ: fluconazole; ICU‐FD: ICU‐free days; L‐AMB: liposomal amphotericin B; LOS: length of hospital stay; VRCZ: voriconazole; M: men; MCFG: micafungin; MEPM: meropenem; MV: mechanical ventilation; PIPC/TAZ: piperacillin/tazobactam; SOFA: Sequential Organ Failure Assessment; VCM: vancomycin; W: women.

Other site was not lung, abdomen, urinary tract, soft tissue, central nervous system, osteoarticular, endocardium, wound, and implant device.
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The incidence of candidemia among patients with sepsis in the FORECAST study [3](#jgf2250-bib-0003){ref-type="ref"} was 1.3%, which was comparable with previous studies[4](#jgf2250-bib-0004){ref-type="ref"} despite significant geographical differences in the Candida species.[5](#jgf2250-bib-0005){ref-type="ref"} Candidemia should always prompt a search for the source despite the possibility of reflecting colonization of an indwelling intravenous catheter. Our results showed differences in patients with candidemia complicated by sepsis. Deep‐seated infections, which lead to secondary candidemia, were associated with high mortality compared to CRBSI. However, underestimation of patients with candidemia is likely as rates of fungal blood culture positivity are lower than for bacteria. Although there is not yet a magic bullet for the diagnosis of this elusive disease, clinical information, such as comorbidities, need for mechanical ventilation, elevated severity score, and low albumin, remains crucially important in providing clues to the diagnosis of candidemia.[1](#jgf2250-bib-0001){ref-type="ref"}

In conclusion, this is the first report to provide a detailed description of septic patients with candidemia in ICU in Japan. In terms of nosocomial infections, candidemia from deep‐seated sources had poorer outcomes compared to those with candidemia caused by CRBSI. Early recognition of fungal infection remains key.
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